Vetter Pharma, has begun the construction of a new clinical manufacturing facility in Des Plaines, Illinois, US.

Bristol Myers Squibb has announced that the FDA has given approval to label updates for Breyanzi and Abecma to treat multiple myeloma.

CAR-Ts, the first of which were initially approved in June 2025, have demonstrated a wealth of efficacy in haematological oncology indications. Credit: Nemes Laszlo via Shutterstock. The US Food and ...

The acquisition will provide Torrent with access to a fast-growing Indian franchise and new therapeutic areas such as ophthalmology. Credit: Sai Thaw Kyar/Shutterstock. Torrent Pharmaceuticals, ...

Oligonucleotides could become a transformative treatment for a range of serious health conditions, but scaling up production is a persistent challenge. A new specialist manufacturing facility in ...

Blockchain has numerous potential benefits for healthcare, which is the topic of episode three in the Blockchain in Scotland series.

There is no excerpt because this is a protected post. This content is password protected. To view it please enter your ...

Blockchain has numerous potential benefits for healthcare, which is the topic of episode three in the Blockchain in Scotland series.

AI has been a buzzword in the pharmaceutical industry for almost a decade, with countless headlines promising to ...

Theravance Biopharma’s partner Viatris has received China's NMPA approval for Yupelri inhalation solution for maintenance treatment of COPD.

The collaboration, set to begin on 1 July, will see Novo Nordisk team up with the telehealth company to offer Wegovy to ...